Real-life experience : sensitivity and specificity of nasal and saliva samples for COVID-19 diagnosis
© 2021. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland..
BACKGROUND: COVID-19 (coronavirus disease 2019) outbreak has spread rapidly around the world, continues to show its effect, and it is not clear how long it will continue. For the diagnosis of COVID-19, it is important to ensure the comfort of the patients and to protect the healthcare workers (HCWs) by reducing the use of protective equipment.
AIMS: To evaluate or assess whether the samples taken by the patient for COVID-19 testing during this pandemic period can be used in real-life experience.
METHODS: Three different samples (nasopharyngeal taken by the healthcare worker, nasopharyngeal, and saliva taken by the patient) from 132 patients were evaluated for the diagnosis of COVID-19. The sensitivity and specificity of the samples in the diagnosis of COVID-19 were compared with real-life experience.
RESULTS: Paired analyzes were performed by comparing each sample taken by the healthcare worker with the sample taken by the patient. The sensitivity of the three samples (nasopharyngeal taken by the healthcare worker, nasopharyngeal, and saliva taken by the patient) in the diagnosis of the COVID-19 was (100%, 98.7%, and 96.1%, respectively) accepted to be accurate.
CONCLUSIONS: The sample taken by the paramedic was compatible compared to the real-life experience for the samples taken by the patient in the COVID-19 pandemic period. During the pandemic that is unknown when it will end, this study demonstrated that taking the sample of the patient alone for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test is a beneficial approach to the protection of the healthcare worker, reducing the need for protective equipment, increasing the patient's comfort and rapid sampling.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:191 |
|---|---|
| Enthalten in: |
Irish journal of medical science - 191(2022), 5 vom: 03. Okt., Seite 2201-2206 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yılmaz, Seda Salman [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 23.09.2022 Date Revised 23.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11845-021-02839-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332695689 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332695689 | ||
| 003 | DE-627 | ||
| 005 | 20231225220108.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11845-021-02839-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1108.xml |
| 035 | |a (DE-627)NLM332695689 | ||
| 035 | |a (NLM)34731445 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yılmaz, Seda Salman |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Real-life experience |b sensitivity and specificity of nasal and saliva samples for COVID-19 diagnosis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.09.2022 | ||
| 500 | |a Date Revised 23.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland. | ||
| 520 | |a BACKGROUND: COVID-19 (coronavirus disease 2019) outbreak has spread rapidly around the world, continues to show its effect, and it is not clear how long it will continue. For the diagnosis of COVID-19, it is important to ensure the comfort of the patients and to protect the healthcare workers (HCWs) by reducing the use of protective equipment | ||
| 520 | |a AIMS: To evaluate or assess whether the samples taken by the patient for COVID-19 testing during this pandemic period can be used in real-life experience | ||
| 520 | |a METHODS: Three different samples (nasopharyngeal taken by the healthcare worker, nasopharyngeal, and saliva taken by the patient) from 132 patients were evaluated for the diagnosis of COVID-19. The sensitivity and specificity of the samples in the diagnosis of COVID-19 were compared with real-life experience | ||
| 520 | |a RESULTS: Paired analyzes were performed by comparing each sample taken by the healthcare worker with the sample taken by the patient. The sensitivity of the three samples (nasopharyngeal taken by the healthcare worker, nasopharyngeal, and saliva taken by the patient) in the diagnosis of the COVID-19 was (100%, 98.7%, and 96.1%, respectively) accepted to be accurate | ||
| 520 | |a CONCLUSIONS: The sample taken by the paramedic was compatible compared to the real-life experience for the samples taken by the patient in the COVID-19 pandemic period. During the pandemic that is unknown when it will end, this study demonstrated that taking the sample of the patient alone for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test is a beneficial approach to the protection of the healthcare worker, reducing the need for protective equipment, increasing the patient's comfort and rapid sampling | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Healthcare worker | |
| 650 | 4 | |a Real-life experience | |
| 650 | 4 | |a Sensitivity | |
| 650 | 4 | |a Specificity | |
| 700 | 1 | |a Kuşkucu, Mert Ahmet |e verfasserin |4 aut | |
| 700 | 1 | |a Sarıbal, Devrim |e verfasserin |4 aut | |
| 700 | 1 | |a Tok, Yeşim |e verfasserin |4 aut | |
| 700 | 1 | |a Özdemir, Yusuf |e verfasserin |4 aut | |
| 700 | 1 | |a Alkan, Sena |e verfasserin |4 aut | |
| 700 | 1 | |a Arsu, Hatice Yaşar |e verfasserin |4 aut | |
| 700 | 1 | |a Yalçın, Metin |e verfasserin |4 aut | |
| 700 | 1 | |a Nohut, Okan |e verfasserin |4 aut | |
| 700 | 1 | |a Balkan, İlker İnanç |e verfasserin |4 aut | |
| 700 | 1 | |a Aygün, Gökhan |e verfasserin |4 aut | |
| 700 | 1 | |a Midilli, Kenan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Irish journal of medical science |d 1945 |g 191(2022), 5 vom: 03. Okt., Seite 2201-2206 |w (DE-627)NLM000148970 |x 1863-4362 |7 nnns |
| 773 | 1 | 8 | |g volume:191 |g year:2022 |g number:5 |g day:03 |g month:10 |g pages:2201-2206 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11845-021-02839-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 191 |j 2022 |e 5 |b 03 |c 10 |h 2201-2206 | ||